Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2010
05/06/2010US20100112081 Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
05/06/2010US20100112079 Thyroid Hormone Analogs and Methods of Use
05/06/2010US20100112066 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
05/06/2010US20100112049 improved bioavailabilty; micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant
05/06/2010US20100112047 Omega 3 fatty acid formulations
05/06/2010US20100112033 Stents coated with no- and s-nitrosothiol-eluting hydrophlic polymeric blends
05/06/2010US20100112030 Role of hedgehog signaling in atherosclerosis and cardiovascular disease
05/06/2010US20100112026 Surfaces, methods and devices employing cell rolling
05/06/2010US20100111946 Inhibiting activation with human anti-factor c3 antibodies and use thereof
05/06/2010US20100111910 Treatment of excessive neovascularization
05/06/2010US20100111909 Dedifferentiation of Adult Mammalian Cardiomyocytes into Cardiac Stem Cells
05/06/2010US20100111898 Conjoint therapy for treating fibrotic diseases
05/06/2010US20100111853 Antibodies that bind to il-12 and methods of purifying the same
05/06/2010DE102008054205A1 Verwendung von Helium-Sauerstoff-Gasgemischen zur Behandlung der pulmonalen arteriellen Hypertonie Use of helium-oxygen gas mixtures for the treatment of pulmonary arterial hypertension
05/06/2010CA2742227A1 Fatty acids for use as a medicament
05/06/2010CA2742181A1 Statin nanoparticles
05/06/2010CA2741934A1 Thienotriazolodiazepine derivatives active on apo a
05/06/2010CA2741783A1 Compounds having tafia inhibitory activity
05/06/2010CA2741658A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
05/06/2010CA2741646A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for disease accompanied by central nervous system disorders
05/06/2010CA2738776A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/05/2010EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
05/05/2010EP2181105A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
05/05/2010EP2180894A1 Methods of activating irs-1 and akt
05/05/2010EP2180891A2 Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same
05/05/2010EP1790655B1 Biologically active peptides
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders
05/05/2010EP1326847B1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
05/05/2010EP1162976B1 16-phenoxy-lipoxin analogs for medical use
05/05/2010EP0946185B2 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
05/05/2010CN1994464B ACEI inhibitor and application thereof
05/05/2010CN1981853B Chinese-medicinal decoction for treating heart disease and cerebral thrombosis and its making method
05/05/2010CN1947792B Method for preparing active protein composition type nano-selenium and its liquid phase storage tech.
05/05/2010CN1943771B The pharmaceutical composition with actions on the NEI network and application thereof
05/05/2010CN1939438B Chinese medicinal composition, its extract containing insect and its preparation
05/05/2010CN1919214B Monascus soft capsule and its preparation method
05/05/2010CN1911219B Medicine composition, and its application
05/05/2010CN1907458B Chinese traditional medicine preparation for treating viral myocarditis
05/05/2010CN1891229B Medicinal composition for preventing or treating metabolic syndrome
05/05/2010CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease
05/05/2010CN1813740B Sublingual pellicles containing naloxone hydrochloride and preparing method thereof
05/05/2010CN1809353B Medicine for prevention of and treatment for arteriosclerosis and hypertension.
05/05/2010CN1799627B Natto kinase oral liquid and its manufacturing method
05/05/2010CN1732953B Dispersible tablet for treating hypertension
05/05/2010CN1729982B Prescription of compound bendazol and hydrochlorothiazide capsule and its preparation process
05/05/2010CN1682707B Pharmaceutical composition comprising fenofibrate and process for its preparation
05/05/2010CN1665496B Use of EPA and DHA in Preparation of medicinie for secondary prevention of neurogenic diseases
05/05/2010CN1663600B Compound preparation composed of ginkgo leaf extracts and medicines promoting cerebral metabolism and its application
05/05/2010CN1649569B Controlled release dosage forms
05/05/2010CN1630629B 酯化合物及其医药用途 Ester compounds and pharmaceutical use
05/05/2010CN1630526B Systems and methods for treating patients with processed lipoaspirate cells
05/05/2010CN1615899B 葛根素口服制剂 Puerarin Oral Formulation
05/05/2010CN1515260B Cinnarizine powder injection containing HPCD, its solid preparation and preparation method
05/05/2010CN1490002B Enalapril drops
05/05/2010CN1416341B Stable emulsion compositions
05/05/2010CN101702881A Use of selected lactic acid bacteria for reducing atherosclerosis
05/05/2010CN101701219A cDNA for encoding rabbit hepatocyte growth factor and expression vector and application thereof
05/05/2010CN101701020A Amide derivate, preparation method and application thereof
05/05/2010CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases
05/05/2010CN101700328A Chinese herbal medicine preparation for treating hemorrhoids
05/05/2010CN101700320A Chinese yeast for treating hemorrhoids
05/05/2010CN101700318A Ointment for treating hemorrhoids and preparation method thereof
05/05/2010CN101700310A Compound traditional Chinese medicine preparation of worm grass for reducing blood sugar
05/05/2010CN101700309A Chinese materia medica preparation for invigorating premodial energy and decreasing blood glucose
05/05/2010CN101700304A Method for controlling quality of circulation plus decoction oral liquid
05/05/2010CN101700297A Medicine for treating hemorrhoids
05/05/2010CN101700285A Application of rumex japonicus in preparing medicines
05/05/2010CN101700275A Pharmaceutical preparation containing axillary choerospondias fruit and preparation method and application thereof
05/05/2010CN101700273A Liquid hard capsule used for dredging channels and preparation method thereof
05/05/2010CN101700271A Traditional Chinese medicine preparation for treating apoplexy sequelae
05/05/2010CN101700267A Detection method of persimmon leaf quality
05/05/2010CN101700266A Saussurea involucrate nano particles and preparation method and application thereof
05/05/2010CN101700265A Application of pseudo-ginseng and extract thereof in preparing medicament for curing and/or preventing diabetic microangiopathies
05/05/2010CN101700263A Method for preparing acer truncatum buge oil microemulsion
05/05/2010CN101700248A Preparation method of Aspirin and Captopril enteric sustained-release capsule
05/05/2010CN101700240A Preparation method of captopril bioadhesive sustained-release capsule
05/05/2010CN101700238A Combined capsule filled with hydrochlorothiazide solid preparation and Benazepril solid preparation
05/05/2010CN101700237A Combined capsule filled with hydrochlorothiazide solid preparation and Aliskiren solid preparation
05/05/2010CN101700229A Prostaglandin E1 long-circulation fat microsphere preparation for intravenous injection and preparation method thereof
05/05/2010CN101700228A Preparation method of amino polysaccharide Aspirin composite nanometer particles
05/05/2010CN101700224A Method for preparing oral chondroitin sulfate nanoemulsion
05/05/2010CN101001629B Medicinal composition
05/04/2010US7709669 Aspirin-triggered lipid mediators
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709640 Inhibitors of phosphorylation of platelet derived growth factor receptor
05/04/2010US7709600 Interaction between the VHL tumor suppressor and hypoxia inducible factor, and assay methods relating thereto
05/04/2010US7709532 administering a drug consisting of (2S,4S,5S,7S)-5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-enzyl]-8-methyl-nonanoic acid (2-arbamoyl-2-methyl-propyl)-amide hemifumarate and efflux protein inhibitor
05/04/2010US7709526 Use of cyclolignans and new cyclolignans
05/04/2010US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709500 Chemical compounds
05/04/2010US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter
05/04/2010US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality
05/04/2010US7709450 Stimulation of vascularization with VEGF-B-186
1 ... 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 ... 1595